Skip to main content
main-content

15-04-2018 | Rheumatoid arthritis | Article

Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial

Genovese MC et al. J Rheumatol 2018; Advance online publication. doi: 10.3899/jrheum.170344

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

https://doi.org/10.3899/jrheum.170344

Related topics